North Korea Tests Missile before key U.S.—China Summit
NTI and the James Martin Center for Nonproliferation Studies have valuable resources to better understand the capacity, background, and history of the North Korean nuclear program.
Pool Re and the Nuclear Threat Initiative Highlight Radiological Material Security Efforts
Pool Re and NTI will host a joint conference to discuss the risks posed by radiological materials in the UK and globally and the threat and urgent need to reduce risks.
Pink Salt, Seven-Foot-Thick Walls, and a State-of-the-Art Centrifuge Plant: A Trip to America’s Nuclear Corridor
Pink Salt, Seven-Foot-Thick Walls, and State-of-the-Art Centrifuges: A Trip to America's Nuclear Corridor
Are States Boycotting the Nuclear Weapon Ban Negotiations Violating Their NPT Commitments?
Are States Boycotting the Nuclear Weapon Ban Negotiations Violating their NPT Obligations?
Preventing a Dirty Bomb: Effective Alternative Technologies for Radiological Security
NTI brochure outlines the radiological security risks associated with cesium-137 blood irradiators used in hospitals around the world.
Science Magazine Interviews New NTI CEO Ernest J. Moniz
Dr. Moniz discussed a range of issues, including U.S. relations with Russia and China, cyber threats, the Iran deal and the vision of a world without nuclear weapons.
New Interactive Maps and Global Incidents and Trafficking Database Reveal 143 Incidents in 19 Countries in 2016
A newly updated edition of the CNS Global Incidents and Trafficking Database finds 143 incidents involving nuclear and other radioactive materials in 19 countries during 2016.
Global Incidents and Trafficking Database Interactive Maps
Visually explore global incidents and trafficking. (CNS)
YGLN: A New Generation Prepares to Tackle Today’s Threats
YGLN: New Generation Prepares to Tackle Today's Threats
Beth Cameron Joins NTI to Lead Global Biological Policy and Programs
Dr. Cameron will oversee the development of a Global Health Security Index, as well as work related to national security risks associated with emerging biotechnologies.